NCT01051895 2026-03-18
CoHIPP
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Active not recruiting
Clinical Trials
244 trialsNCT06810427 2026-03-18
CervImage
Carilion Clinic
Phase NA Active not recruiting
NCT03842982 2026-03-16
CHIPPI
Centre Oscar Lambret
Phase 3 Active not recruiting
NCT06286462 2026-03-16
CATSystem
University of Kansas Medical Center
Phase NA Active not recruiting
NCT04266886 2026-03-13
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05763199 2026-03-12
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy
University of California, Davis
Phase 2 Active not recruiting
NCT03586661 2026-03-11
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05824468 2026-03-10
Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
Sun Yat-sen University
Phase 2 Active not recruiting
NCT05824481 2026-03-10
Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer
Sun Yat-sen University
Phase 2 Active not recruiting
NCT00515372 2026-03-09
Depression Treatment and Screening in Ovarian Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02194387 2026-03-09
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04604613 2026-03-09
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
M.D. Anderson Cancer Center
Active not recruiting
NCT05677048 2026-03-09
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT00188539 2026-03-06
Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels
University Health Network, Toronto
Phase 2 Active not recruiting
NCT00957450 2026-03-06
Intra-Pelvic Organ Motion for Cervix Cancer Patient Using Imaging
University Health Network, Toronto
Active not recruiting
NCT04454450 2026-03-06
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT01970722 2026-03-05
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT06028932 2026-03-05
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
Yale University
Phase 2 Active not recruiting
NCT04742075 2026-02-27
DOVACC
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 2 Active not recruiting
NCT05063916 2026-02-27
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06240598 2026-02-27
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03943173 2026-02-25
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06263283 2026-02-24
KYOCOL
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Active not recruiting
NCT03617679 2026-02-23
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
University of Colorado, Denver
Phase 2 Active not recruiting
NCT04065269 2026-02-20
ATARI
Institute of Cancer Research, United Kingdom
Phase 2 Active not recruiting
NCT04258813 2026-02-20
ONE TEAM
Duke University
Phase NA Active not recruiting
NCT03252938 2026-02-19
INSIGHT
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 1 Active not recruiting
NCT03579316 2026-02-18
Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03045965 2026-02-17
HOPPSA
Göteborg University
Phase NA Active not recruiting
NCT04251416 2026-02-17
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
Yale University
Phase 2 Active not recruiting
NCT04310826 2026-02-17
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06397573 2026-02-17
Ablative Stereotactic MR-Guided Adaptive Reirradiation
Baptist Health South Florida
Phase NA Active not recruiting
NCT02397083 2026-02-13
LEVER
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03734692 2026-02-12
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
University of Pittsburgh
Phase 1/2 Active not recruiting
NCT03008408 2026-02-11
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04781088 2026-02-11
Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT05761951 2026-02-11
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04068753 2026-02-10
STAR
University of Oklahoma
Phase 2 Active not recruiting
NCT02884648 2026-02-06
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04459273 2026-02-05
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT03120624 2026-02-04
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
Mayo Clinic
Phase 1 Active not recruiting
NCT04906187 2026-01-30
MONIALC
Institut Bergonié
Phase NA Active not recruiting
NCT05415527 2026-01-29
OPTIMOVA
Institut Bergonié
Phase NA Active not recruiting
NCT06483997 2026-01-29
Diet, Hepcidin, and Chemotherapy RDI
George Washington University
Active not recruiting
NCT03984695 2026-01-28
SHE-WOMEN
University of Kansas Medical Center
Phase NA Active not recruiting
NCT05786456 2026-01-28
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
City of Hope Medical Center
Phase NA Active not recruiting
NCT04242823 2026-01-23
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
Beth Israel Deaconess Medical Center
Phase NA Active not recruiting
NCT02658565 2026-01-22
Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation
University of Kentucky
Phase NA Active not recruiting
NCT05645146 2026-01-22
Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Active not recruiting
NCT06715241 2026-01-22
COLIBRI-2
ARCAGY/ GINECO GROUP
Phase 2 Active not recruiting